medigraphic.com
ISSN 1561-2945 (Print)

2017, Number 2

<< Back Next >>

Revista Cubana de Cirugía 2017; 56 (2)

Primary neuroendocrine breast tumor found in a man

Gómez TCA, García AE, Niño RÁE

Language: Spanish
References: 30
Page: 79-87
PDF size: 158.49 Kb.


ABSTRACT

Breast cancer in men is a rare and poorly studied malady. The prognosis and management is far from being ideal and from the achievements of the female breast cancer treatment. Even rare are neuroendocine breast tumors. In most of cases, its behavior is uncertain and its management is controversial. This was the report of a male patient aged 67 years, with history of right breast mass, initially diagnosed as a poorly differentiated tumor with later immunohistochemical test that reported the existence of a primary neuroendocrine breast tumor. The early diagnosis of breast cancer in men represents a real challenge for the health systems. Therefore, our knowledge about its physiopathology and risk factors must be expanded.


REFERENCES

  1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11

  2. Ibañez RG, Calderón ME, Márquez ZD. Cáncer de mama en hombres: Situación actual a nivel mundial y nacional. Rev Chil Cir 2011 Feb;63(1):95-101.

  3. Mesa G, Matute G, Estrada M, Ocampo A, Restrepo C, Estrada J. Cáncer mamario en hombres. Rev Colomb Cir. 2011;26(4):293-307.

  4. Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A. Male breast cancer. Crit Rev Oncol Hematol. 2010;73:141-55.

  5. Korde LA, Zujewski JA, Kamin L, Giordano S, Domchehek S, Anderson WF, et al. Multidisciplinary meeting on male breast cancer: Summary and research recommendations. J Clin Oncol. 2010;28:2114-22.

  6. Gómez RC, Zambrana F, Serreno M, López M, Casado E. Male breast cancer. Cancer Treatment Reviews. 2010;36:451-7.

  7. Barra V, Eguía L, San JSH, Fernández RL, Chana A, et al. Carcinoma neuroendocrino primario de mama: rara neoplasia a propósito de un caso. Cir Esp. 2014;92(Espec Congr):898.

  8. Molinete-Carrillo M, Blay L, Vega L, Abad JM, Camps J, Feliu X. Tumores neuroendocrinos de mama. A propósito de 2 casos. Cir Esp. 2014;92(Espec Congr):899

  9. Gómez RÁ, Reina SJ, Mota D. Tumor neuroendocrino de la mama: A próposito de un caso. Rev. venez. oncol. 2010;22(2):126-129.

  10. Gogia A, Raina V, Deo SV, Shukla NK, Mohanti BK. Male breast cáncer: A single institute experience. Indian Journal Of Cancer. 2015;52(4):526-9.

  11. Yu X, Yang H, Yu Y, Zou D, Miao L. A Prognostic Analysis of Male Breas Cancer (MBC) Compared with Post-Menopausal Female Breas Cancer (FBC). Plos ONE [serial con the Internet]. 2015[cited July 17,2016];10(8):1-9.

  12. Herrera-Muñoz A, Giménez-Ruiza F, Nievas-Sorianob M, Mallol-Goytrea MC, Velasco-Albendeab J, Fiol-Ruiza G. Tumor neuroendocrino de la mama: presentación de un caso y revisión de la literatura. Progresos de Obstetricia y Ginecología. 2015;(58):187-90.

  13. Angarita FA, Rodríguez JL, Meek E, Sánchez JO, Tawil M, Torregrosa L. Locallyadvanced primary neuroendocrine carcinoma of the breast: Case report and review of the literatura. World J Surg Oncol. 2013 Jun 5;11:128.

  14. Humphries M, Jordan V, Speirs V. Obesity and male breasr cáncer: provocative parallels?. BMC Medicine [serial on the Internet]. 2015[cited July 17,2016];13(1):1-9.

  15. Hung MH, Liu CJ, Teng CJ, Hu YW, Yeh CM, Chen SC, et al. (2016) Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study. PLoS ONE 11(2): e0148597. doi:10.1371/journal.pone.0148597

  16. de Souza Timoteo A, Albuquerque B, Pascoto Moura P, de Oliveira Ramos C, Agnez-Lima L, Lajus T, et al. Identification of a new large genomic BRCA2 deletion associated with high risk male breast cancer. Hereditary Cancer In Clinical Practice [serial on the Internet]. 2015[cited July 17, 2016];13(1):1-5.

  17. Benjamin M, Riker A. A Case of Male Breast Cancer with a BRCA Gene Mutation. Ochsner Journal. 2015;15(4):448-51.

  18. Gargiulo P, Pensabene M, Milano M, Arpino G, Giuliano M, De Placido S, et al. Long-term survival and BRCA status in male breast cancer: a retrospective singlecenter analysis. BMC Cancer. 2016;161-11.

  19. Tandon M, Panwar P, Garg P, Chintamani, Sirai F. Neurofibromatosis with male brast cáncer - risk factor or co-insidence? Repor of two rare cases. Breas Disease [serial on the internet]. 2015[cited July 17, 2016];35(1):29-32.

  20. Yalaza M, Inan A, Bozer M, Male Breast Cancer. Meme Sagligi Dergisi / Journal Of Breast Health [serial on the Internet]. 2016[cited July 17 2016];12(1):1-8.

  21. Uthamalingam M, Periyasamy K. Paget´s Disease of Nipple in Male Breast with Cancer. Journal Of Clinical & Diagnostic Research [serial con the Internet]. 2016[cited July 17 2016];10(2):14-16.

  22. Balleyguier C, Ayadi S, Van Nguyen K, Vanel D, Dromain C, Sigal R. BIRADS™ classification in mammography. European Journal Of Radiology. 2007;61(2):192-4.

  23. Park S, Koo J, Kim M, Park H, Lee J, Lee K, et al. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Annals Of Oncology [serial on the Internet]. 2011[cited October 13 2016];22(8):1755-62. Available from: ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.1042

  24. Niemeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R. Androgen receptor in breast cancer: expresision in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Modern Pathology. 2010;23:205-12.

  25. Di Lauro L, Barba M, Pizzuti L, Vici P, Sergi D, Maugeri-Saccà M, et al. Androgen receptor and antiandrogen therapy in male breast cancer. Cancer Letters [serial on the Internet]. 2015[cited October 13,2016];368(1):20-5. Available from: http://eprints.whiterose.ac.uk/94406/3/Androgen_receptor_and_antiandrogen_ther apy_in_male_breast_cancer.pdf

  26. Mu-Min Shao, Siu Ki Chan, Alex MC Yu, Christopher CF Lam, Julia YS Tsang, Philip CW Lui, et al. Keratin expression in breast cancers. Virchows Archiv European Journal of Pathology. 2012;(461):313-22.

  27. Hu ZI, Liu C, Fisher PR, Cohen JA. Intracystic Papillary Carcinoma of the Breast in a Male Patient. Rare Tumors. 2016;8(1):6050.

  28. Kornegoor R, Verschuur-Maes A, Buerger H, Hogenes M, de Bruin P, van Diest P, et al. Immunophenotyping of male breast cancer. Histopathology [serial on the Internet]. 2012[cited October 13,2016];61(6):1145-55. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22056953

  29. F. Tang, B. Wei, Z. Tian, M.Z. Gilcreas, L. Huo, C.T. Albarracin Invasive mammary carcinoma with neuroendocrine differentiation: Histological features and diagnostic challenges Histopathology. 2011; pp. 106-115.

  30. Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, el al. Male breast cáncer. Evolution of tratment and prognostic factros. Analysis of 489 cases, Crit Rev Oncol/Hematol. 2010;73:246-54




2020     |     www.medigraphic.com